Structure

Physi-Chem Properties

Molecular Weight:  432.21
Volume:  437.784
LogP:  1.112
LogD:  1.09
LogS:  -3.65
# Rotatable Bonds:  5
TPSA:  106.97
# H-Bond Aceptor:  7
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.538
Synthetic Accessibility Score:  5.958
Fsp3:  0.75
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.162
MDCK Permeability:  7.453188300132751e-05
Pgp-inhibitor:  0.964
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.033
20% Bioavailability (F20%):  0.237
30% Bioavailability (F30%):  0.946

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.822
Plasma Protein Binding (PPB):  66.73616790771484%
Volume Distribution (VD):  0.377
Pgp-substrate:  41.87315368652344%

ADMET: Metabolism

CYP1A2-inhibitor:  0.008
CYP1A2-substrate:  0.04
CYP2C19-inhibitor:  0.009
CYP2C19-substrate:  0.075
CYP2C9-inhibitor:  0.009
CYP2C9-substrate:  0.07
CYP2D6-inhibitor:  0.029
CYP2D6-substrate:  0.102
CYP3A4-inhibitor:  0.084
CYP3A4-substrate:  0.187

ADMET: Excretion

Clearance (CL):  1.568
Half-life (T1/2):  0.429

ADMET: Toxicity

hERG Blockers:  0.079
Human Hepatotoxicity (H-HT):  0.146
Drug-inuced Liver Injury (DILI):  0.612
AMES Toxicity:  0.102
Rat Oral Acute Toxicity:  0.93
Maximum Recommended Daily Dose:  0.913
Skin Sensitization:  0.92
Carcinogencity:  0.742
Eye Corrosion:  0.25
Eye Irritation:  0.126
Respiratory Toxicity:  0.972

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470229

Natural Product ID:  NPC470229
Common Name*:   JMLPJPQQKYBNBI-WXCZESARSA-N
IUPAC Name:   n.a.
Synonyms:   1,7-O-Diacetylgeopyxin A
Standard InCHIKey:  JMLPJPQQKYBNBI-WXCZESARSA-N
Standard InCHI:  InChI=1S/C24H32O7/c1-12-15-6-7-16-23(5)17(10-19(31-14(3)26)24(16,11-15)20(12)27)22(4,21(28)29)9-8-18(23)30-13(2)25/h15-19H,1,6-11H2,2-5H3,(H,28,29)/t15-,16+,17-,18+,19+,22-,23+,24-/m1/s1
SMILES:  CC(=O)O[C@H]1CC[C@@]([C@@H]2[C@]1(C)[C@@H]1CC[C@@H]3C[C@@]1([C@H](C2)OC(=O)C)C(=O)C3=C)(C)C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1873045
PubChem CID:   51361445
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33235 geopyxis sp. az0066 Species Pyronemataceae Eukaryota n.a. n.a. n.a. PMID[22264149]
NPO32738 geopyxis aff. majalis Species Pyronemataceae Eukaryota n.a. n.a. n.a. PMID[22264149]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens Potency n.a. 19952.6 nM PMID[450066]
NPT154 Individual Protein Mothers against decapentaplegic homolog 3 Homo sapiens Potency n.a. 10000.0 nM PMID[450066]
NPT477 Individual Protein DNA dC->dU-editing enzyme APOBEC-3G Homo sapiens Potency n.a. 3981.1 nM PMID[450066]
NPT478 Individual Protein Ataxin-2 Homo sapiens Potency n.a. 39810.7 nM PMID[450066]
NPT101 Individual Protein Glucagon-like peptide 1 receptor Homo sapiens Potency n.a. 22387.2 nM PMID[450066]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 4109.5 nM PMID[450066]
NPT50 Individual Protein Tyrosyl-DNA phosphodiesterase 1 Homo sapiens Potency n.a. 2059.6 nM PMID[450066]
NPT160 Individual Protein TAR DNA-binding protein 43 Homo sapiens Potency n.a. 15848.9 nM PMID[450066]
NPT2 Others Unspecified Potency n.a. 6513.1 nM PMID[450066]
NPT861 Individual Protein Isocitrate dehydrogenase [NADP] cytoplasmic Homo sapiens Potency n.a. 6513.1 nM PMID[450066]
NPT2 Others Unspecified Potency n.a. 39810.7 nM PMID[450066]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470229 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9888 High Similarity NPC329910
0.9886 High Similarity NPC475118
0.9775 High Similarity NPC470232
0.967 High Similarity NPC471038
0.9663 High Similarity NPC470386
0.9663 High Similarity NPC470385
0.9663 High Similarity NPC47853
0.9659 High Similarity NPC470230
0.9462 High Similarity NPC163963
0.9462 High Similarity NPC289148
0.9462 High Similarity NPC52899
0.9462 High Similarity NPC46848
0.9457 High Similarity NPC474793
0.9451 High Similarity NPC470387
0.9451 High Similarity NPC200054
0.9451 High Similarity NPC29410
0.9438 High Similarity NPC211403
0.9438 High Similarity NPC198242
0.9432 High Similarity NPC471043
0.9362 High Similarity NPC275990
0.9362 High Similarity NPC304832
0.9362 High Similarity NPC76866
0.9362 High Similarity NPC148628
0.9362 High Similarity NPC286519
0.9362 High Similarity NPC88203
0.9362 High Similarity NPC246736
0.9362 High Similarity NPC214946
0.9355 High Similarity NPC287676
0.9341 High Similarity NPC98639
0.9263 High Similarity NPC277074
0.9263 High Similarity NPC87927
0.9263 High Similarity NPC122811
0.9263 High Similarity NPC209298
0.9255 High Similarity NPC236585
0.9247 High Similarity NPC38296
0.9247 High Similarity NPC28864
0.9247 High Similarity NPC162459
0.9247 High Similarity NPC16911
0.9247 High Similarity NPC78427
0.9247 High Similarity NPC20479
0.9247 High Similarity NPC38471
0.9247 High Similarity NPC98837
0.9222 High Similarity NPC250753
0.9167 High Similarity NPC98603
0.9149 High Similarity NPC470388
0.9149 High Similarity NPC293866
0.9121 High Similarity NPC294263
0.9072 High Similarity NPC138908
0.9072 High Similarity NPC200957
0.9062 High Similarity NPC139347
0.9062 High Similarity NPC216114
0.9053 High Similarity NPC252614
0.9043 High Similarity NPC472028
0.9043 High Similarity NPC89099
0.9032 High Similarity NPC13949
0.8989 High Similarity NPC259009
0.898 High Similarity NPC201908
0.898 High Similarity NPC176949
0.898 High Similarity NPC166993
0.8969 High Similarity NPC84928
0.8947 High Similarity NPC94906
0.8947 High Similarity NPC267921
0.8936 High Similarity NPC10864
0.8925 High Similarity NPC210214
0.8901 High Similarity NPC80401
0.8889 High Similarity NPC112895
0.8889 High Similarity NPC273155
0.8889 High Similarity NPC231278
0.8889 High Similarity NPC218123
0.8876 High Similarity NPC471042
0.8866 High Similarity NPC469985
0.8866 High Similarity NPC96217
0.8854 High Similarity NPC71706
0.8854 High Similarity NPC148279
0.8854 High Similarity NPC75941
0.8854 High Similarity NPC471790
0.8842 High Similarity NPC26270
0.883 High Similarity NPC219353
0.8804 High Similarity NPC476168
0.8788 High Similarity NPC186054
0.8778 High Similarity NPC153604
0.8776 High Similarity NPC474558
0.8776 High Similarity NPC96268
0.8776 High Similarity NPC202793
0.8776 High Similarity NPC301787
0.8764 High Similarity NPC190704
0.8764 High Similarity NPC471034
0.8763 High Similarity NPC309388
0.8763 High Similarity NPC124544
0.8763 High Similarity NPC475803
0.875 High Similarity NPC41971
0.875 High Similarity NPC37047
0.875 High Similarity NPC180733
0.875 High Similarity NPC471037
0.8737 High Similarity NPC253586
0.8737 High Similarity NPC96839
0.8723 High Similarity NPC288906
0.8723 High Similarity NPC263135
0.871 High Similarity NPC244356
0.871 High Similarity NPC181594
0.871 High Similarity NPC224060
0.871 High Similarity NPC144739
0.87 High Similarity NPC63841
0.87 High Similarity NPC211224
0.8687 High Similarity NPC4115
0.8687 High Similarity NPC295366
0.8687 High Similarity NPC37600
0.8687 High Similarity NPC222833
0.8673 High Similarity NPC159442
0.8673 High Similarity NPC470310
0.866 High Similarity NPC121218
0.866 High Similarity NPC253886
0.866 High Similarity NPC14634
0.8632 High Similarity NPC234564
0.8632 High Similarity NPC104568
0.8627 High Similarity NPC470281
0.8627 High Similarity NPC329953
0.8617 High Similarity NPC153775
0.8617 High Similarity NPC261333
0.8617 High Similarity NPC302008
0.8617 High Similarity NPC215271
0.8617 High Similarity NPC292374
0.8617 High Similarity NPC129004
0.8617 High Similarity NPC91772
0.8617 High Similarity NPC29247
0.8617 High Similarity NPC111524
0.8617 High Similarity NPC191094
0.8617 High Similarity NPC289539
0.8617 High Similarity NPC104371
0.8617 High Similarity NPC101233
0.8614 High Similarity NPC274827
0.8602 High Similarity NPC299185
0.8602 High Similarity NPC471901
0.8602 High Similarity NPC476934
0.86 High Similarity NPC471474
0.86 High Similarity NPC88833
0.86 High Similarity NPC96333
0.86 High Similarity NPC61071
0.8586 High Similarity NPC13149
0.8586 High Similarity NPC101842
0.8571 High Similarity NPC170615
0.8557 High Similarity NPC293890
0.8557 High Similarity NPC108371
0.8542 High Similarity NPC469810
0.8539 High Similarity NPC471036
0.8539 High Similarity NPC291320
0.8529 High Similarity NPC474786
0.8529 High Similarity NPC320383
0.8529 High Similarity NPC471093
0.8529 High Similarity NPC137104
0.8526 High Similarity NPC266431
0.8526 High Similarity NPC138245
0.8526 High Similarity NPC84018
0.8526 High Similarity NPC197158
0.8526 High Similarity NPC231060
0.8526 High Similarity NPC471624
0.8515 High Similarity NPC232133
0.8515 High Similarity NPC473410
0.8515 High Similarity NPC471094
0.8515 High Similarity NPC469984
0.8511 High Similarity NPC471902
0.8511 High Similarity NPC473690
0.8511 High Similarity NPC287118
0.8511 High Similarity NPC199543
0.85 High Similarity NPC103172
0.85 High Similarity NPC164600
0.85 High Similarity NPC265127
0.85 High Similarity NPC56656
0.85 High Similarity NPC12823
0.8495 Intermediate Similarity NPC180849
0.8495 Intermediate Similarity NPC470378
0.8495 Intermediate Similarity NPC149761
0.8495 Intermediate Similarity NPC261994
0.8485 Intermediate Similarity NPC312900
0.8478 Intermediate Similarity NPC56413
0.8478 Intermediate Similarity NPC4309
0.8469 Intermediate Similarity NPC295276
0.8462 Intermediate Similarity NPC471252
0.8447 Intermediate Similarity NPC29505
0.8444 Intermediate Similarity NPC299963
0.8444 Intermediate Similarity NPC473336
0.8444 Intermediate Similarity NPC146683
0.8444 Intermediate Similarity NPC471044
0.8438 Intermediate Similarity NPC264979
0.8438 Intermediate Similarity NPC135548
0.8438 Intermediate Similarity NPC140242
0.8431 Intermediate Similarity NPC469983
0.8431 Intermediate Similarity NPC131903
0.8427 Intermediate Similarity NPC472504
0.8421 Intermediate Similarity NPC169751
0.8421 Intermediate Similarity NPC469982
0.8421 Intermediate Similarity NPC272635
0.8404 Intermediate Similarity NPC475416
0.8404 Intermediate Similarity NPC198054
0.84 Intermediate Similarity NPC47281
0.8387 Intermediate Similarity NPC57954
0.8387 Intermediate Similarity NPC213832
0.837 Intermediate Similarity NPC57469
0.837 Intermediate Similarity NPC33768
0.837 Intermediate Similarity NPC174619

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470229 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8211 Intermediate Similarity NPD8034 Phase 2
0.8211 Intermediate Similarity NPD8035 Phase 2
0.8152 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.79 Intermediate Similarity NPD7638 Approved
0.7857 Intermediate Similarity NPD7748 Approved
0.7835 Intermediate Similarity NPD6079 Approved
0.7822 Intermediate Similarity NPD7640 Approved
0.7822 Intermediate Similarity NPD7639 Approved
0.7812 Intermediate Similarity NPD5328 Approved
0.781 Intermediate Similarity NPD6881 Approved
0.781 Intermediate Similarity NPD6899 Approved
0.7788 Intermediate Similarity NPD7128 Approved
0.7788 Intermediate Similarity NPD5739 Approved
0.7788 Intermediate Similarity NPD6675 Approved
0.7788 Intermediate Similarity NPD6402 Approved
0.7778 Intermediate Similarity NPD6115 Approved
0.7778 Intermediate Similarity NPD6114 Approved
0.7778 Intermediate Similarity NPD6118 Approved
0.7778 Intermediate Similarity NPD6697 Approved
0.7755 Intermediate Similarity NPD6399 Phase 3
0.7714 Intermediate Similarity NPD5697 Approved
0.7679 Intermediate Similarity NPD6319 Approved
0.7664 Intermediate Similarity NPD7102 Approved
0.7664 Intermediate Similarity NPD6883 Approved
0.7664 Intermediate Similarity NPD7290 Approved
0.7653 Intermediate Similarity NPD7515 Phase 2
0.7642 Intermediate Similarity NPD7320 Approved
0.7642 Intermediate Similarity NPD6011 Approved
0.7624 Intermediate Similarity NPD7902 Approved
0.7619 Intermediate Similarity NPD6008 Approved
0.7615 Intermediate Similarity NPD4632 Approved
0.7593 Intermediate Similarity NPD6649 Approved
0.7593 Intermediate Similarity NPD8130 Phase 1
0.7593 Intermediate Similarity NPD6847 Approved
0.7593 Intermediate Similarity NPD6650 Approved
0.7593 Intermediate Similarity NPD6617 Approved
0.7593 Intermediate Similarity NPD6869 Approved
0.757 Intermediate Similarity NPD6013 Approved
0.757 Intermediate Similarity NPD6373 Approved
0.757 Intermediate Similarity NPD6014 Approved
0.757 Intermediate Similarity NPD6372 Approved
0.757 Intermediate Similarity NPD6012 Approved
0.7565 Intermediate Similarity NPD7492 Approved
0.7556 Intermediate Similarity NPD6117 Approved
0.7553 Intermediate Similarity NPD4788 Approved
0.7547 Intermediate Similarity NPD5701 Approved
0.7525 Intermediate Similarity NPD5221 Approved
0.7525 Intermediate Similarity NPD5222 Approved
0.7525 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7523 Intermediate Similarity NPD6882 Approved
0.7523 Intermediate Similarity NPD8297 Approved
0.7522 Intermediate Similarity NPD6054 Approved
0.7521 Intermediate Similarity NPD7736 Approved
0.75 Intermediate Similarity NPD6616 Approved
0.7477 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD6116 Phase 1
0.7451 Intermediate Similarity NPD5173 Approved
0.7444 Intermediate Similarity NPD3703 Phase 2
0.7436 Intermediate Similarity NPD7078 Approved
0.7431 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7411 Intermediate Similarity NPD6009 Approved
0.7391 Intermediate Similarity NPD6370 Approved
0.7368 Intermediate Similarity NPD6059 Approved
0.7353 Intermediate Similarity NPD4697 Phase 3
0.7347 Intermediate Similarity NPD6672 Approved
0.7347 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD5737 Approved
0.7339 Intermediate Similarity NPD4634 Approved
0.7333 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7632 Discontinued
0.7328 Intermediate Similarity NPD7604 Phase 2
0.7327 Intermediate Similarity NPD7900 Approved
0.7327 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6868 Approved
0.732 Intermediate Similarity NPD6409 Approved
0.732 Intermediate Similarity NPD3618 Phase 1
0.732 Intermediate Similarity NPD6684 Approved
0.732 Intermediate Similarity NPD7521 Approved
0.732 Intermediate Similarity NPD5330 Approved
0.732 Intermediate Similarity NPD7334 Approved
0.732 Intermediate Similarity NPD7146 Approved
0.7308 Intermediate Similarity NPD5286 Approved
0.7308 Intermediate Similarity NPD4696 Approved
0.7308 Intermediate Similarity NPD5285 Approved
0.7304 Intermediate Similarity NPD5983 Phase 2
0.7304 Intermediate Similarity NPD6015 Approved
0.7304 Intermediate Similarity NPD6016 Approved
0.7292 Intermediate Similarity NPD4786 Approved
0.7288 Intermediate Similarity NPD8293 Discontinued
0.7282 Intermediate Similarity NPD4755 Approved
0.7282 Intermediate Similarity NPD6084 Phase 2
0.7282 Intermediate Similarity NPD6083 Phase 2
0.7257 Intermediate Similarity NPD7115 Discovery
0.7245 Intermediate Similarity NPD3573 Approved
0.7241 Intermediate Similarity NPD5988 Approved
0.7238 Intermediate Similarity NPD5223 Approved
0.7203 Intermediate Similarity NPD6336 Discontinued
0.7193 Intermediate Similarity NPD6335 Approved
0.7179 Intermediate Similarity NPD8328 Phase 3
0.7172 Intermediate Similarity NPD6903 Approved
0.717 Intermediate Similarity NPD5225 Approved
0.717 Intermediate Similarity NPD4633 Approved
0.717 Intermediate Similarity NPD5226 Approved
0.717 Intermediate Similarity NPD5211 Phase 2
0.717 Intermediate Similarity NPD5224 Approved
0.7168 Intermediate Similarity NPD6274 Approved
0.7167 Intermediate Similarity NPD7319 Approved
0.7143 Intermediate Similarity NPD4700 Approved
0.7143 Intermediate Similarity NPD8133 Approved
0.7143 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD7101 Approved
0.713 Intermediate Similarity NPD7100 Approved
0.7129 Intermediate Similarity NPD6411 Approved
0.7111 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD6317 Approved
0.7103 Intermediate Similarity NPD5174 Approved
0.7103 Intermediate Similarity NPD5175 Approved
0.7087 Intermediate Similarity NPD5695 Phase 3
0.7087 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD3667 Approved
0.7059 Intermediate Similarity NPD4202 Approved
0.7059 Intermediate Similarity NPD7507 Approved
0.7048 Intermediate Similarity NPD5696 Approved
0.7043 Intermediate Similarity NPD6313 Approved
0.7043 Intermediate Similarity NPD6314 Approved
0.7037 Intermediate Similarity NPD5141 Approved
0.6957 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6944 Remote Similarity NPD4754 Approved
0.6942 Remote Similarity NPD6033 Approved
0.6939 Remote Similarity NPD3133 Approved
0.6939 Remote Similarity NPD3666 Approved
0.6939 Remote Similarity NPD3665 Phase 1
0.6932 Remote Similarity NPD4224 Phase 2
0.6931 Remote Similarity NPD6673 Approved
0.6931 Remote Similarity NPD6904 Approved
0.6931 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6931 Remote Similarity NPD6080 Approved
0.6931 Remote Similarity NPD6101 Approved
0.6923 Remote Similarity NPD5777 Approved
0.6923 Remote Similarity NPD6081 Approved
0.6909 Remote Similarity NPD6412 Phase 2
0.6893 Remote Similarity NPD5779 Approved
0.6893 Remote Similarity NPD5778 Approved
0.6889 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6889 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6887 Remote Similarity NPD4225 Approved
0.6882 Remote Similarity NPD3702 Approved
0.6875 Remote Similarity NPD7525 Registered
0.6864 Remote Similarity NPD6909 Approved
0.6864 Remote Similarity NPD6908 Approved
0.6864 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6847 Remote Similarity NPD4729 Approved
0.6847 Remote Similarity NPD6686 Approved
0.6847 Remote Similarity NPD4730 Approved
0.6847 Remote Similarity NPD5128 Approved
0.6847 Remote Similarity NPD5168 Approved
0.6818 Remote Similarity NPD4767 Approved
0.6818 Remote Similarity NPD4768 Approved
0.68 Remote Similarity NPD6098 Approved
0.6796 Remote Similarity NPD7637 Suspended
0.6786 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6778 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6778 Remote Similarity NPD5360 Phase 3
0.6768 Remote Similarity NPD3668 Phase 3
0.6765 Remote Similarity NPD4753 Phase 2
0.6735 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6735 Remote Similarity NPD4221 Approved
0.6735 Remote Similarity NPD4223 Phase 3
0.6726 Remote Similarity NPD5249 Phase 3
0.6726 Remote Similarity NPD5251 Approved
0.6726 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5247 Approved
0.6726 Remote Similarity NPD5135 Approved
0.6726 Remote Similarity NPD5169 Approved
0.6726 Remote Similarity NPD5250 Approved
0.6726 Remote Similarity NPD5248 Approved
0.6723 Remote Similarity NPD6921 Approved
0.6719 Remote Similarity NPD6334 Approved
0.6719 Remote Similarity NPD6333 Approved
0.67 Remote Similarity NPD5329 Approved
0.6667 Remote Similarity NPD5215 Approved
0.6667 Remote Similarity NPD5127 Approved
0.6667 Remote Similarity NPD5208 Approved
0.6667 Remote Similarity NPD5216 Approved
0.6667 Remote Similarity NPD6001 Approved
0.6667 Remote Similarity NPD5217 Approved
0.6635 Remote Similarity NPD5693 Phase 1
0.6635 Remote Similarity NPD5284 Approved
0.6635 Remote Similarity NPD5281 Approved
0.6635 Remote Similarity NPD6050 Approved
0.6634 Remote Similarity NPD5279 Phase 3
0.663 Remote Similarity NPD4244 Approved
0.663 Remote Similarity NPD4789 Approved
0.663 Remote Similarity NPD4245 Approved
0.6609 Remote Similarity NPD6053 Discontinued
0.6604 Remote Similarity NPD5210 Approved
0.6604 Remote Similarity NPD4629 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data